L. Brooks

970 total citations
21 papers, 702 citations indexed

About

L. Brooks is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, L. Brooks has authored 21 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 7 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in L. Brooks's work include Viral-associated cancers and disorders (6 papers), Parvovirus B19 Infection Studies (5 papers) and Cancer Research and Treatments (2 papers). L. Brooks is often cited by papers focused on Viral-associated cancers and disorders (6 papers), Parvovirus B19 Infection Studies (5 papers) and Cancer Research and Treatments (2 papers). L. Brooks collaborates with scholars based in United Kingdom, United States and Italy. L. Brooks's co-authors include Lawrence S. Young, Alan B. Rickinson, Gerald Niedobitek, Andrea Lear, John S. Greenspan, Deborah Greenspan, Richard Lau, J Crocker, A. B. Rickinson and Hermann Herbst and has published in prestigious journals such as Nucleic Acids Research, Blood and Journal of Virology.

In The Last Decade

L. Brooks

20 papers receiving 680 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Brooks United Kingdom 12 536 226 195 163 103 21 702
Takanori Oda Japan 10 336 0.6× 185 0.8× 184 0.9× 92 0.6× 115 1.1× 19 701
Yasmin Ench United States 14 484 0.9× 277 1.2× 216 1.1× 251 1.5× 121 1.2× 18 698
I J Su Taiwan 14 303 0.6× 319 1.4× 212 1.1× 188 1.2× 226 2.2× 22 827
I. Gorin France 17 745 1.4× 358 1.6× 267 1.4× 339 2.1× 151 1.5× 39 1.1k
Ari K. Saemundsen Sweden 8 536 1.0× 164 0.7× 260 1.3× 225 1.4× 124 1.2× 10 690
Winyou Mitarnun Thailand 13 332 0.6× 90 0.4× 272 1.4× 69 0.4× 120 1.2× 50 665
Marjorie Bernstein-Singer United States 11 430 0.8× 89 0.4× 257 1.3× 207 1.3× 270 2.6× 14 860
Paola Chabay Argentina 19 892 1.7× 161 0.7× 633 3.2× 252 1.5× 215 2.1× 58 1.0k
Maura M. Bacchi Brazil 14 320 0.6× 90 0.4× 242 1.2× 93 0.6× 70 0.7× 28 472
J. A. Gastaut France 18 232 0.4× 199 0.9× 192 1.0× 202 1.2× 271 2.6× 40 937

Countries citing papers authored by L. Brooks

Since Specialization
Citations

This map shows the geographic impact of L. Brooks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Brooks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Brooks more than expected).

Fields of papers citing papers by L. Brooks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Brooks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Brooks. The network helps show where L. Brooks may publish in the future.

Co-authorship network of co-authors of L. Brooks

This figure shows the co-authorship network connecting the top 25 collaborators of L. Brooks. A scholar is included among the top collaborators of L. Brooks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Brooks. L. Brooks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brooks, L., Cyaandi Dove, Lee C. Rogers, et al.. (2025). Diabetes-Related Extremity Amputation Depression and Distress (DREADD): A Multimethod Study. Seminars in Vascular Surgery. 38(1). 94–100. 1 indexed citations
2.
Brooks, L., et al.. (2024). Reassessing ‘good’ medical practice and the climate crisis. Journal of Medical Ethics. 51(6). 365–370. 4 indexed citations
3.
Brooks, L., et al.. (2024). Comparative effectiveness of disease-modifying antirheumatic drugs for patients with cardiac sarcoidosis. Lara D. Veeken. 64(6). 3303–3308. 2 indexed citations
4.
6.
Brooks, L., et al.. (2016). Teaching, learning and assessment of medical ethics at the UK medical schools. Journal of Medical Ethics. 43(9). 606–612. 23 indexed citations
7.
Atkins, Dan, et al.. (2012). PRM30 A Model to Predict Risk of Non-Adherence to Medications Highlighted in CMS Star-Ratings. Value in Health. 15(4). A164–A164. 2 indexed citations
8.
Witney, Adam A., L. Brooks, Neil G. Stoker, et al.. (2011). B G@Sbase--a microbial gene expression and comparative genomic database. Nucleic Acids Research. 40(D1). D605–D609. 3 indexed citations
9.
Brooks, L., Alice Sullivan, Jenny O’Nions, et al.. (2002). E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. British Journal of Cancer. 86(2). 263–268. 27 indexed citations
10.
O’Nions, Jenny, L. Brooks, Alice Sullivan, et al.. (2001). p73 is over-expressed in vulval cancer principally as the Δ2 isoform. British Journal of Cancer. 85(10). 1551–1556. 46 indexed citations
11.
Brooks, L. & J. Alero Thomas. (1995). The significance of Epstein Barr virus in the pathogenesis of lymphoid and epithelial neoplasia. Current Diagnostic Pathology. 2(3). 163–174. 11 indexed citations
12.
Sam, Choon‐Kook, L. Brooks, Gerald Niedobitek, et al.. (1993). Analysis of epstein‐barr virus infection in nasopharyngeal biopsies from a group at high risk of nasopharyngeal carcinoma. International Journal of Cancer. 53(6). 957–962. 85 indexed citations
13.
Brooks, L., Andrea Lear, Lawrence S. Young, & Alan B. Rickinson. (1993). Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. Journal of Virology. 67(6). 3182–3190. 99 indexed citations
14.
Vega‐López, F., L. Brooks, Hazel M. Dockrell, et al.. (1993). Sequence and immunological characterization of a serine-rich antigen from Mycobacterium leprae. Infection and Immunity. 61(5). 2145–2153. 19 indexed citations
15.
Niedobitek, Gerald, Hermann Herbst, Lawrence S. Young, et al.. (1992). Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue. Blood. 79(10). 2520–2526. 131 indexed citations
16.
Niedobitek, Gerald, Lawrence S. Young, Richard Lau, et al.. (1991). Epstein-Barr Virus Infection in Oral Hairy Leukoplakia: Virus Replication in the Absence of a Detectable Latent Phase. Journal of General Virology. 72(12). 3035–3046. 153 indexed citations
17.
Young, Lawrence S., S. Finerty, L. Brooks, et al.. (1989). Epstein-Barr virus gene expression in malignant lymphomas induced by experimental virus infection of cottontop tamarins. Journal of Virology. 63(5). 1967–1974. 52 indexed citations
18.
Paré, P. D., Lindsay Lawson, & L. Brooks. (1983). Patterns of response to inhaled bronchodilators in asthmatics.. PubMed. 127(6). 680–5. 22 indexed citations
19.
Baile, E. M., Peter D. Paré, L. Brooks, & James C. Hogg. (1982). Relationship between regional lung volume and regional pulmonary vascular resistance. Journal of Applied Physiology. 52(4). 914–920. 6 indexed citations
20.
Paré, P. D., L. Brooks, & E. M. Baile. (1981). Effect of systemic venous hypertension on pulmonary function and lung water. Journal of Applied Physiology. 51(3). 592–597. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026